NewsRamp is a PR & Newswire Technology platform that enhances press release distribution by adapting content to align with how and where audiences consume information. Recognizing that most internet activity occurs outside of search, NewsRamp improves content discovery by programmatically curating press releases into multiple unique formats—news articles, blog posts, persona-based TLDRs, videos, audio, and Zero-Click content—and distributing this content through a network of news sites, blogs, forums, podcasts, video platforms, newsletters, and social media.
FAQ: HeartBeam's Global Recognition in 12-Lead ECG Innovation
TL;DR
HeartBeam's second-place global ranking in 12-lead ECG innovation positions it as a strong competitor to GE Healthcare in the portable cardiac diagnostics market.
HeartBeam's synthesis-ECG system captures heart signals in three dimensions and synthesizes them into a 12-lead ECG using compact, portable devices.
HeartBeam's technology enables high-quality cardiac monitoring outside hospitals, improving arrhythmia assessment accessibility and potentially saving lives in remote locations.
HeartBeam's 3D ECG system transforms cardiac care with portable devices that deliver cardiologist-level data anywhere, backed by 17 global patents.
Found this article helpful?
Share it with your network and spread the knowledge!
HeartBeam was featured in an article discussing its recognition as a Global IP and Technology Leader in Portable Cardiac Diagnostics, ranking second worldwide in 12-lead ECG innovation among 243 firms analyzed, trailing only GE Healthcare.
HeartBeam was recognized by PatentVest's "Total Cardiac Intelligence" report, which identified the company as a Global IP and Technology Leader in Portable Cardiac Diagnostics.
HeartBeam's proprietary synthesis-ECG system captures the heart's electrical signals in three noncoplanar dimensions and synthesizes them into a 12-lead ECG, allowing physicians to obtain cardiologist-level ECG data from compact devices.
HeartBeam addresses one of modern medicine's most persistent challenges: delivering high-quality cardiac monitoring for arrhythmia assessment wherever patients are, outside traditional hospital settings.
The company is cleared for arrhythmia assessment today, and ischemia assessment is a future goal for the technology.
HeartBeam is creating the first-ever cable-free 12-lead ECG capable of capturing the heart's electrical signals from three dimensions, designed for portable devices that can be used wherever the patient is.
The company holds 13 U.S. and 4 international-issued patents related to technology enablement for their cardiac monitoring platform.
For more information, visit www.HeartBeam.com, view the full article at https://ibn.fm/3ADRP, or check the company's newsroom at https://ibn.fm/BEAT.
The technology allows physicians to identify cardiac health trends and acute conditions and direct patients to appropriate care outside medical facilities, redefining the future of cardiac health management by providing powerful cardiac insights wherever the patient is.
Curated from NewMediaWire
